RENFLEXIS
Google image searchProduct monograph
Active ingredient
infliximab, 100 MG/VIAL
DIN: 02470373
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE USE VIAL
Schedule: Prescription / Schedule D
Company: SAMSUNG BIOEPIS CO., LTD
Date: 22-MAR-2018
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AB — Tumor necrosis factor alpha (TNF-alpha) inhibitors (ATC, ATC/DDD)
- L04AB02 — INFLIXIMAB (ATC/DDD)
Reference brand drug: Remicade
Pharmaceutical standard: MFR
